Primary prevention of gastroduodenal ulcer: what is the evidence?
|Published in||Revue médicale suisse. 2006, vol. 2, no. 83, p. 2337-2338, 2340, 2342-2343|
|Abstract||Primary prevention of gastroduodenal ulcer and its major complication, gastrointestinal bleeding, has been studied mainly in the intensive care environment. Proton pump inhibitors (PPIs), H2-receptor antagonists and sucralfate have proved effective. By extension, PPIs are inappropriately prescribed in a variety of clinical situations. In contrast, they are probably underused in patients chronically treated by nonsteroidal anti-inflammatory drugs. This article reviews the situations in which an increased ulcer risk justifies primary prevention. Validated prophylactic options are also addressed.|
|Keywords||Aged, 80 and over — Anti-Ulcer Agents — Female — Humans — Male — Middle Aged — Peptic Ulcer — Primary Prevention — Risk Factors|
This document has no fulltext available yet, but you can contact its author by using the form below.
|PFAENDER, S., PERRIER, Arnaud, NENDAZ, Mathieu. Primary prevention of gastroduodenal ulcer: what is the evidence?. In: Revue médicale suisse, 2006, vol. 2, n° 83, p. 2337-2338, 2340, 2342-2343. https://archive-ouverte.unige.ch/unige:9586|